Alimera Sciences to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference

Rhea-AI Summary

Alimera Sciences, a pharmaceutical firm focusing on ophthalmology, announced that President and CEO Rick Eiswirth will present at the Inaugural Emerging Growth Virtual Conference on March 17-18, 2021. Investors can view his presentation on March 17 after registering for the conference. An archived replay will also be accessible on the conference website. Alimera is dedicated to addressing retinal diseases, which often lack effective treatments and significantly impact aging populations. For more information, visit www.alimerasciences.com.

ATLANTA, March 11, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that President and CEO Rick Eiswirth will present at Maxim Group’s Inaugural Emerging Growth Virtual Conference to be held March 17-18, 2021.

Investors can view Mr. Eiswirth’s general corporate presentation on March 17 once they register for the conference here, and an archived replay of the presentation will be available via the conference website. Investors can also request a 1x1 meeting with Mr. Eiswirth to be arranged following the conclusion of the conference.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com

For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com

FAQ

What is the date of the Inaugural Emerging Growth Virtual Conference for Alimera Sciences?

The Inaugural Emerging Growth Virtual Conference will be held on March 17-18, 2021.

Who is presenting for Alimera Sciences at the conference?

Rick Eiswirth, President and CEO of Alimera Sciences, will present at the conference.

How can investors view the presentation by Alimera Sciences' CEO?

Investors can view the presentation by registering for the conference on March 17.

Will there be a replay available of the presentation from Alimera Sciences?

Yes, an archived replay of the presentation will be available on the conference website.

What is the focus of Alimera Sciences?

Alimera Sciences specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, particularly for retinal diseases.